Publications by authors named "Robin A Howe"

Claim this Profile
R
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.
Sara E Boyd, Mandy Wootton, Robin A Howe, David M Livermore, Alasdair P Macgowan

J Antimicrob Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic epidemiology reveals geographical clustering of multidrug-resistant Escherichia coli ST131 associated with bacteraemia in Wales.
Rhys T White, Matthew J Bull, Clare R Barker, Julie M Arnott, Mandy Wootton, Robin A Howe

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusion.
Mandy Wootton, Leanne Davies, Katherine Pitman, Robin A Howe

Clin Microbiol Infect· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy.
Mandy Wootton, Alasdair P MacGowan, Robin A Howe

J Antimicrob Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
Derek F J Brown, Mandy Wootton, Robin A Howe

J Antimicrob Chemother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan.
Lim S Jones, Maria J Carvalho, Mark A Toleman, P Lewis White, Thomas R Connor, Robin A Howe

Antimicrob Agents Chemother· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Luminex xTAG Gastrointestinal Pathogen Panel and the Savyon Diagnostics Gastrointestinal Infection Panel for the detection of enteric pathogens in clinical samples.
Michael D Perry, Sally A Corden, Robin A Howe

J Med Microbiol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India.
Lim S Jones, Mark A Toleman, Janis L Weeks, Robin A Howe, Timothy R Walsh

Antimicrob Agents Chemother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics.
Saira Khan, Anne Tøndervik, Håvard Sletta, Geir Klinkenberg, Charlotte Emanuel, Robin A Howe

Antimicrob Agents Chemother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Containing antibiotic resistance while treating community-acquired pneumonia.
Matt P Wise, Robin A Howe, Christopher C Butler

Arch Intern Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A promising target for treatment of multidrug-resistant bacterial infections.
Martin S Davey, Jonathan M Tyrrell, Robin A Howe, Timothy R Walsh, Bernhard Moser

Antimicrob Agents Chemother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphipathic antimicrobial peptides--from biophysics to therapeutics?
Christopher E Dempsey, Ayman Hawrani, Robin A Howe, Timothy R Walsh

Protein Pept Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activity.
Ayman Hawrani, Robin A Howe, Timothy R Walsh, Christopher E Dempsey

Biochim Biophys Acta· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
Mandy Wootton, Tim R Walsh, Lorna Macfarlane, Robin A Howe

J Antimicrob Chemother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.
Mandy Wootton, Timothy R Walsh, Eleri M Davies, Robin A Howe

Infect Control Hosp Epidemiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides.
Ayman Hawrani, Robin A Howe, Timothy R Walsh, Christopher E Dempsey

J Biol Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Over the counter medicines: Don't include trimethoprim.
Robin A Howe

BMJ· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA).
Andreas Voss, Johan W Mouton, Erika P van Elzakker, Ron G Hendrix, Wil Goessens, Robin A Howe

Ann Clin Microbiol Antimicrob· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.
Mandy Wootton, Alasdair P MacGowan, Timothy R Walsh, Robin A Howe

J Clin Microbiol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates.
Virginia C Gould, Aki Okazaki, Robin A Howe, Matthew B Avison

J Antimicrob Chemother· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hGISA: seek and ye shall find.
Robin A Howe, Timothy R Walsh

Lancet· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages.
Robin A Howe, Alastair Monk, Mandy Wootton, Timothy R Walsh, Mark C Enright

Emerg Infect Dis· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
Robin A Howe, Mandy Wootton, Alan R Noel, Karen E Bowker, Timothy R Walsh

Antimicrob Agents Chemother· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.
Timothy R Walsh, Robin A Howe

Annu Rev Microbiol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.
Matthew B Avison, Peter M Bennett, Robin A Howe, Timothy R Walsh

J Antimicrob Chemother· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis